Id |
Subject |
Object |
Predicate |
Lexical cue |
T3276 |
0-37 |
Sentence |
denotes |
Intracerebroventricular drug infusion |
T54 |
0-37 |
Sentence |
denotes |
Intracerebroventricular drug infusion |
T3277 |
38-196 |
Sentence |
denotes |
Rats were divided into two groups: vehicle (saline)-treated and soluble TNFp55 receptor (sTNFp55R, 50 μg/ml; Sigma-Aldrich Co., St. Louis, MO)-treated groups. |
T55 |
38-196 |
Sentence |
denotes |
Rats were divided into two groups: vehicle (saline)-treated and soluble TNFp55 receptor (sTNFp55R, 50 μg/ml; Sigma-Aldrich Co., St. Louis, MO)-treated groups. |
T3278 |
197-356 |
Sentence |
denotes |
The dosage of sTNFp55R was determined as the highest dose that induced SE of comparable severity in 100% of animals with 5% mortality in the preliminary study. |
T56 |
197-356 |
Sentence |
denotes |
The dosage of sTNFp55R was determined as the highest dose that induced SE of comparable severity in 100% of animals with 5% mortality in the preliminary study. |
T3279 |
357-474 |
Sentence |
denotes |
Animals were anesthetized (Zolretil, 50 mg/kg, i.m.; Virbac Laboratories, France) and placed in a stereotaxic frames. |
T57 |
357-474 |
Sentence |
denotes |
Animals were anesthetized (Zolretil, 50 mg/kg, i.m.; Virbac Laboratories, France) and placed in a stereotaxic frames. |
T3280 |
475-785 |
Sentence |
denotes |
For the osmotic pump implantation, holes were drilled through the skull to introduce a brain infusion kit 1 (Alzet, Cupertino, CA) into the right lateral ventricle (1 mm posterior; 1.5 mm lateral; - 3.5 mm depth; flat skull position with bregma as reference), according to the atlas of Paxinos and Watson [24]. |
T58 |
475-785 |
Sentence |
denotes |
For the osmotic pump implantation, holes were drilled through the skull to introduce a brain infusion kit 1 (Alzet, Cupertino, CA) into the right lateral ventricle (1 mm posterior; 1.5 mm lateral; - 3.5 mm depth; flat skull position with bregma as reference), according to the atlas of Paxinos and Watson [24]. |
T3281 |
786-896 |
Sentence |
denotes |
The infusion kit was sealed with dental cement and connected to an osmotic pump (1007D, Alzet, Cupertino, CA). |
T59 |
786-896 |
Sentence |
denotes |
The infusion kit was sealed with dental cement and connected to an osmotic pump (1007D, Alzet, Cupertino, CA). |
T3282 |
897-963 |
Sentence |
denotes |
The pump was placed in a subcutaneous pocket in the dorsal region. |
T60 |
897-963 |
Sentence |
denotes |
The pump was placed in a subcutaneous pocket in the dorsal region. |
T3283 |
964-1025 |
Sentence |
denotes |
Animals received 0.5 μl/hr of vehicle or compound for 1 week. |
T61 |
964-1025 |
Sentence |
denotes |
Animals received 0.5 μl/hr of vehicle or compound for 1 week. |
T3284 |
1026-1089 |
Sentence |
denotes |
Therefore, the dose of sTNFp55R was 0.6 μg/day per each animal. |
T62 |
1026-1089 |
Sentence |
denotes |
Therefore, the dose of sTNFp55R was 0.6 μg/day per each animal. |
T3285 |
1090-1150 |
Sentence |
denotes |
The compounds began to be immediately infused after surgery. |
T63 |
1090-1150 |
Sentence |
denotes |
The compounds began to be immediately infused after surgery. |
T3286 |
1151-1274 |
Sentence |
denotes |
Since the volume of vasogenic edema peaked at 2-3 days after SE in our previous studies [5-8,20], we chose this time point. |
T64 |
1151-1274 |
Sentence |
denotes |
Since the volume of vasogenic edema peaked at 2-3 days after SE in our previous studies [5-8,20], we chose this time point. |
T3287 |
1275-1432 |
Sentence |
denotes |
Thus, our experimental schedules at least inhibit the function of TNF-α from 3 days prior to SE to 4 days after SE when the volume of vasogenic edema peaked. |
T65 |
1275-1432 |
Sentence |
denotes |
Thus, our experimental schedules at least inhibit the function of TNF-α from 3 days prior to SE to 4 days after SE when the volume of vasogenic edema peaked. |